NORTHWEST BIOTHERAPEUTICS INC (NWBO) Total liabilities 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) total liabilities at each fiscal year-end, per SEC filings.
$128.9MFY2025 · since FY2016: $79.4M → $128.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $128.9M | +21.9% |
| FY2024 | $105.7M | +41.1% |
| FY2023 | $74.9M | -45.1% |
| FY2022 | $136.4M | -16.9% |
| FY2021 | $164.2M | -58.5% |
| FY2020 | $395.8M | +610.7% |
| FY2019 | $55.7M | -22.5% |
| FY2018 | $71.8M | -25.3% |
| FY2017 | $96.2M | +21.2% |
| FY2016 | $79.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating marginNWBO Operating cash flowNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Shareholders’ equityNWBO overview →